Lung cancer Posts on Medivizor
Navigation Menu

Lung cancer Posts on Medivizor

Durvalumab improves time to disease progression in previously treatment non-small cell lung cancer

Posted by on Sep 21, 2017 in Lung cancer | 0 comments

In a nutshell This study examined the safety and effectiveness of durvalumab (Imfinzi) in patients with stage III non-small cell lung cancer. This study concluded that durvalumab delayed time to disease progression. Some background Chemotherapy and radiation are the standard treatment options for stage III non-small cell lung cancer (NSCLC, cancer...

Read More

Can Video Gaming Build Resilience? You Decide…

Can Video Gaming Build Resilience?   You Decide…

Posted by on Sep 20, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer, Rheumatoid Arthritis, Stroke | 0 comments

In the aftermath of Hurricanes Harvey and Irma, a recent news story discussed the mental health consequences of disasters. Researcher Jean Rhodes of University of Massachusetts Boston studied the mental health of young parents living in New Orleans before and after Hurricane Katrina. RISK- Resilience In Survivors of Katrina is the project’s name. An...

Read More

Highlights of the European Society of Medical Oncology Meeting

Highlights of the European Society of Medical Oncology Meeting

Posted by on Sep 15, 2017 in Blog, Breast cancer, Lung cancer, Prostate cancer | 0 comments

From September 8 through 12th, over 24,000 oncologists and oncology researchers attended the European Society of Medical Oncology Meeting (ESMO), the equivalent of the American Society of Clinical Oncology Meeting (ASCO) held in the US. This year’s event focused on connecting researchers to practitioners in a meaningful way. Here are some research...

Read More

Does mutation status predict the effectiveness of targeted therapies in NSCLC?

Posted by on Sep 10, 2017 in Lung cancer | 0 comments

In a nutshell This study examined the use of a type of targeted therapy called immune checkpoint inhibitors to treat advanced non-small-cell lung cancer (NSCLC). The authors concluded that for patients who had a genetic mutation (change) called KRAS, ICIs were more effective than chemotherapy. They suggest that the presence of KRAS mutations could...

Read More

Combining radiation with chemotherapy to treat advanced NSCLC that has spread around the body

Posted by on Sep 10, 2017 in Lung cancer | 0 comments

In a nutshell This study examined whether patients with non-small-cell lung cancer that has spread to multiple sites in the body may benefit from radiation combined with chemotherapy. The authors of this trial concluded that for patients with high tumor volume, high dose radiation with effective chemotherapy could benefit.  Some background In...

Read More

Identifying factors to predict treatment prognosis in EGFR positive non-small-cell lung cancer

Posted by on Sep 10, 2017 in Lung cancer | 0 comments

In a nutshell The authors examined whether the lymphocyte to monocyte ratio (LMR) could predict outcome in patients with late stage EGFR positive non-small-cell lung cancer (NSCLC). They concluded LMR could be beneficial in predicting outcome for patients with EGFR positive NSCLC patients receiving first-line EGFR-TKIs.   Some background Some...

Read More

Treatment that activates the immune system to kill tumors in extensive-stage small cell lung cancer

Posted by on Sep 4, 2017 in Lung cancer | 0 comments

In a nutshell This trial looked at therapy that activates the immune system to kill cancerous tumors in patients with extensive stage small cell lung cancer (ES-CLC). The authors concluded pembrolizumab (Keytruda) is tolerable and a promising treatment for patients with heavily treated ES-SCLC. Some background Extensive-stage small cell lung...

Read More

Recommended treatments for small cell lung cancer

Posted by on Sep 4, 2017 in Lung cancer | 0 comments

In a nutshell This review summarizes the most effective treatments for small cell lung cancer, based on recent clinical trial data. Some background There are two types of small-cell lung cancer. Limited stage (LS-SCLC) is cancer that is confined to a single area. Extensive stage (ES-SCLC) has spread past a single area. Recommendations for...

Read More